Skip to content
DataLookout
Menu

NCT05692830

Towards a Wearable Alcohol Biosensor: Examining the Accuracy of BAC Estimates From New-Generation Transdermal Technology Using Large-Scale Human Testing and Machine Learning Algorithms

StatusCompleted
PhaseNot specified
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 7 versions: 6 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 8 words Show 4 more changesShow less
    • Trial completed
    • Primary completion date changed from estimate of Aug 1, 2026 to Sep 5, 2026
    • Site details revised
    • Publications: details revised at 25 of 27 entries
  2. Minor Study description expanded, about 38 wordsv6
  3. Minor Site contact updated
    • Study description expanded, about 5 words
    v5
  4. Notable Start date: Apr 3, 2022 to Oct 22, 2022v4
  5. Notable Phase: Not applicable to Not specified
    • Primary endpoints: 2 to 3
    • Study description expanded, about 12 words
    • Study arms: 2 to 0
    v3
  6. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Transdermal estimates of alcohol consumption
Timeframe: Across the 14 day period of the study
Transdermal estimates of drinking risk level
Timeframe: Across the 14 day period of the study
Transdermal estimates of blood alcohol concentration
Timeframe: Across the 14 day period of the study

Arms and interventions

Drugs: Alcohol

Sites

1 site in 1 country

  • University of Illinois at Urbana-ChampaignChampaign, Illinois, United States